{ "cik": 1676725, "cik_padded": "0001676725", "entityName": "IDEAYA Biosciences, Inc.", "fiscal_years": [ { "accn": "0001193125-26-054533", "filed": "2026-02-17", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2368000.0, "cash": 112825000.0, "eps_diluted": -1.28, "free_cash_flow": -73466000.0, "net_income": -113698000.0, "operating_cash_flow": -71098000.0, "operating_income": -159313000.0, "revenue": 218710000.0, "stockholders_equity": 1022934000.0, "total_assets": 1109324000.0, "total_liabilities": 86390000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08445315142521415, "net_margin": -0.5198573453431484, "operating_margin": -0.7284211970188834, "revenue_growth_yoy": 30.244285714285713, "roa_avg2y": -0.10181538137784514, "roa_period_end": -0.10249304982133262, "roe_avg2y": -0.10921573176067598, "roe_period_end": -0.11114891087792564 } }, { "accn": "0001193125-26-054533", "filed": "2026-02-17", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3857000.0, "cash": 84378000.0, "eps_diluted": -3.36, "free_cash_flow": -251441000.0, "net_income": -274477000.0, "operating_cash_flow": -247584000.0, "operating_income": -326975000.0, "revenue": 7000000.0, "stockholders_equity": 1059147000.0, "total_assets": 1124091000.0, "total_liabilities": 64944000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06131726757475591, "revenue_growth_yoy": -0.7006628180457558, "roa_avg2y": -0.3095476672867537, "roa_period_end": -0.24417685045071974, "roe_avg2y": -0.3267122435704011, "roe_period_end": -0.2591491077253677 } }, { "accn": "0001193125-26-054533", "filed": "2026-02-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2368000.0, "cash": 157018000.0, "eps_diluted": -1.96, "free_cash_flow": -117592000.0, "net_income": -112961000.0, "operating_cash_flow": -115224000.0, "operating_income": -134429000.0, "revenue": 23385000.0, "stockholders_equity": 621090000.0, "total_assets": 649316000.0, "total_liabilities": 28226000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04544590961052344, "revenue_growth_yoy": -0.54084938446133, "roa_avg2y": -0.2178012793012528, "roa_period_end": -0.17396922299773915, "roe_avg2y": -0.23277849043578608, "roe_period_end": -0.1818754125811074 } }, { "accn": "0001193125-26-054533", "filed": "2026-02-17", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3443000.0, "cash": 68632000.0, "eps_diluted": -1.42, "free_cash_flow": -90618000.0, "net_income": -58655000.0, "operating_cash_flow": -87175000.0, "operating_income": -62502000.0, "revenue": 50931000.0, "stockholders_equity": 349455000.0, "total_assets": 387969000.0, "total_liabilities": 38514000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11021161522942868, "net_margin": -1.1516561622587422, "operating_margin": -1.227189727278082, "revenue_growth_yoy": 0.8228051966644, "roa_avg2y": -0.152486104539617, "roa_period_end": -0.151184759607082, "roe_avg2y": -0.18020827412672494, "roe_period_end": -0.16784707616145136 } }, { "accn": "0000950170-25-022183", "filed": "2025-02-18", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2644000.0, "cash": 92046000.0, "eps_diluted": -1.41, "free_cash_flow": -58423000.0, "net_income": -49762000.0, "operating_cash_flow": -55779000.0, "operating_income": -50268000.0, "revenue": 27941000.0, "stockholders_equity": 301514000.0, "total_assets": 381347000.0, "total_liabilities": 79833000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.26477377501542215, "revenue_growth_yoy": 0.4300849626369127, "roa_avg2y": -0.14644151991712967, "roa_period_end": -0.13049007858984074, "roe_avg2y": -0.19913243215123214, "roe_period_end": -0.165040429300132 } }, { "accn": "0001564590-22-010922", "filed": "2024-02-20", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 493000.0, "cash": 72037000.0, "eps_diluted": -1.4, "free_cash_flow": 54970000.0, "net_income": -34495000.0, "operating_cash_flow": 55463000.0, "operating_income": -35344000.0, "revenue": 19538000.0, "stockholders_equity": 198274000.0, "total_assets": 298269000.0, "total_liabilities": 99995000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5043273449872399, "roa_avg2y": -0.16774868091521386, "roa_period_end": -0.11565063751177629, "roe_avg2y": -0.23098763200010713, "roe_period_end": -0.17397641647417209 } }, { "accn": "0001564590-22-010922", "filed": "2023-03-07", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1353000.0, "cash": 34067000.0, "free_cash_flow": -40666000.0, "net_income": -41975000.0, "operating_cash_flow": -39313000.0, "operating_income": -44271000.0, "stockholders_equity": 100400000.0, "total_assets": 113001000.0, "total_liabilities": 12601000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12550796812749004, "roa_avg2y": -0.40063567208483264, "roa_period_end": -0.3714568897620375, "roe_avg2y": -1.6316178185493275, "roe_period_end": -0.4180776892430279 } }, { "accn": "0001564590-22-010922", "filed": "2022-03-18", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1708000.0, "cash": 20505000.0, "free_cash_flow": -29328000.0, "net_income": -34346000.0, "operating_cash_flow": -27620000.0, "operating_income": -36417000.0, "stockholders_equity": -48948000.0, "total_assets": 96541000.0, "total_liabilities": 7098000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_period_end": -0.35576594400306605, "roe_avg2y": 1.0619135220368854 } }, { "accn": "0001564590-21-014676", "filed": "2021-03-23", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 1757000.0, "cash": 5961000.0, "free_cash_flow": -13981000.0, "net_income": -11862000.0, "operating_cash_flow": -12224000.0, "operating_income": -14438000.0, "stockholders_equity": -15739000.0 }, "period_end": "2017-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": 1.1939006592521766 } }, { "accn": "0001564590-20-012501", "filed": "2020-03-24", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -4132000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-054533", "filed": "2026-02-17", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001676725.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001676725.json" }, "ticker": "IDYA" }